Ptc Therapeutics Inc (PTCT)

07:07 AM

Wellington Management Group LLP Sells 3,105,676 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

07:07 AM

Apr 03, 2025

Pictet Asset Management Holding SA Buys 381,319 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Apr 03, 2025

Apr 03, 2025

PTC Therapeutics (NASDAQ:PTCT) Given New $75.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Apr 03, 2025

Apr 03, 2025

Gastroparesis Market Growth to Accelerate in Forecast Period - openPR.com

Apr 03, 2025

Apr 03, 2025

KLP Kapitalforvaltning AS Purchases New Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Apr 03, 2025

Apr 03, 2025

Trexquant Investment LP Purchases 95,418 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Apr 03, 2025

Apr 03, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Sold by Thrivent Financial for Lutherans - MarketBeat

Apr 03, 2025

Apr 02, 2025

(PTCT) Technical Data - news.stocktradersdaily.com

Apr 02, 2025

Apr 01, 2025

PTC Therapeutics (NASDAQ:PTCT) Stock Price Down 8.8% After Analyst Downgrade - MarketBeat

Apr 01, 2025

Mar 31, 2025

Raymond James Financial Inc. Makes New $2.20 Million Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Mar 31, 2025

Mar 31, 2025

Natixis Advisors LLC Acquires New Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Mar 31, 2025

Mar 30, 2025

11 Best Gene Therapy Stocks to Buy According to Analysts - Insider Monkey

Mar 30, 2025

Mar 30, 2025

PTC Therapeutics says Duchenne drug Translarna is no longer authorized in EU - MSN

Mar 30, 2025

Mar 29, 2025

Cibc World Markets Corp Acquires Shares of 7,127 PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Mar 29, 2025

Mar 28, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StreetInsider.com

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics faces EC setback on Translarna in Europe By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Sector Update: Health Care Stocks Mixed Friday Afternoon - MarketScreener

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics Faces EU Setback on Translarna - TipRanks

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics says EC will not renew market authorization for muscle disorder drug - MarketScreener

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics stock slips as EU ends Translarna nod (PTCT) - Seeking Alpha

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics faces EC setback on Translarna in Europe - Investing.com

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics (PTCT) Faces EU Setback for DMD Drug Translarna - GuruFocus

Mar 28, 2025

Mar 28, 2025

European Commission Declines To Renew Marketing Authorization Of Translarna Duchenne Muscular Disorder - Benzinga

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics says EC not to renew market authorization for muscle disorder drug - MarketScreener

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics Provides Regulatory Update on Translarna™ (ataluren) in Europe - Quantisnow

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics Loses EU Authorization for Translarna in Duchenne Muscular Dystrophy - MarketScreener

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics: European Commission Decides To Adopt CHMP Negative Opinion On Translarna - Nasdaq

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics says European Commission will remove muscle disorder drug - MarketScreener

Mar 28, 2025

Mar 28, 2025

PTC Therapeutics Provides Regulatory Update On Translarna(TM) (Ataluren) In Europe - MarketScreener

Mar 28, 2025

Mar 26, 2025

Sector Gamma AS Purchases Shares of 65,250 PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Mar 26, 2025

Mar 26, 2025

Proficio Capital Partners LLC Invests $758,000 in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Mar 26, 2025

Mar 25, 2025

A Shareholder alert for PTC Therapeutics, Inc was sent by Bronstein, Gewirtz and Grossman, LLC to Lead Class Action Lawsuit! - ACCESS Newswire

Mar 25, 2025

Mar 25, 2025

AlphaQuest LLC Has $49,000 Stock Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Mar 25, 2025

Mar 24, 2025

PTC Therapeutics (NASDAQ:PTCT) Sets New 52-Week HighShould You Buy? - MarketBeat

Mar 24, 2025

Mar 24, 2025

First Week of May 16th Options Trading For PTC Therapeutics - Nasdaq

Mar 24, 2025

Mar 24, 2025

Leigh Syndrome Treatment Market Size in 7MM is expected to grow - openPR

Mar 24, 2025

Mar 23, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Mar 23, 2025

Mar 22, 2025

Stephanie Okey Sells 5,000 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock - MarketBeat

Mar 22, 2025

Mar 21, 2025

Insider Sell Alert: Eric Pauwels Sells Shares of PTC Therapeutics Inc (PTCT) - GuruFocus

Mar 21, 2025

Mar 21, 2025

Charles Schwab Investment Management Inc. Trims Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Mar 21, 2025

Mar 20, 2025

PTC Therapeutics reports progress in PKU treatment study By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

PTC Therapeutics Reveals New Sepiapterin Data From Phase 3 Study In Patients With Inherited Disorder, FDA Decision Expected In July - Benzinga

Mar 20, 2025

Mar 20, 2025

PTC Therapeutics reports progress in PKU treatment study - Investing.com India

Mar 20, 2025

Mar 19, 2025

PTCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PTC Therapeutics, Inc Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Mar 19, 2025

Mar 19, 2025

JPMorgan Chase & Co. Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $78.00 - MarketBeat

Mar 19, 2025

Mar 19, 2025

PTC Therapeutics (NASDAQ:PTCT) Hits New 12-Month High After Analyst Upgrade - MarketBeat

Mar 19, 2025